Proflavine derivatives as fluorescent imaging agents of amyloid deposits

被引:8
作者
Garin, Dominique [1 ]
Oukhatar, Fatima [2 ,3 ]
Mahon, Andrew B. [4 ]
Try, Andrew C. [4 ]
Dubois-Dauphin, Michel [5 ]
Laferla, Frank M. [6 ]
Demeunynck, Martine [2 ,3 ]
Sallanon, Marcelle Moulin [1 ]
Chierici, Sabine [2 ,3 ]
机构
[1] Univ Grenoble 1, INSERM, Unit U877, La Tronche, France
[2] Univ Grenoble 1, Dept Chim Mol, UMR 5250, F-38041 Grenoble 9, France
[3] Univ Grenoble 1, CNRS, ICMG FR 2607, F-38041 Grenoble 9, France
[4] Macquarie Univ, Dept Chem & Biomol Sci, N Ryde, NSW 2109, Australia
[5] Univ Geneva, CMU, Dept Pathol & Immunol, Geneva 4, Switzerland
[6] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA
关键词
Proflavine; Click chemistry; Fluorescent markers; Amyloid deposits imaging; ALZHEIMERS-DISEASE; LIPOIC ACID; IN-VIVO; BETA; CURCUMIN; FIBRILS; PLAQUES;
D O I
10.1016/j.bmcl.2011.03.010
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
A series of proflavine derivatives for use to further image A beta amyloid deposits were synthesized and characterized. Aged 3xTg-AD (23 months old) mice hippocampus sections incubated with these derivatives revealed preferential labeling of amyloid plaques. Furthermore an in vitro binding study showed an inhibitory effect, although moderate, of these compounds on A beta(40) fibril formation. This study highlights the potential of proflavine as a molecular scaffold for designing new A beta imaging agents, its native fluorescence allowing in vitro neuropathological staining in AD damaged brain sections. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2203 / 2206
页数:4
相关论文
共 16 条
[1]
Radioligand development for PET imaging of β-amyloid (AD)-current status [J].
Cai, Lisheng ;
Innis, Robert B. ;
Pike, Victor W. .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (01) :19-52
[2]
Protein misfolding, functional amyloid, and human disease [J].
Chiti, Fabrizio ;
Dobson, Christopher M. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :333-366
[3]
Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model [J].
Garcia-Alloza, M. ;
Borrelli, L. A. ;
Rozkalne, A. ;
Hyman, B. T. ;
Bacskai, B. J. .
JOURNAL OF NEUROCHEMISTRY, 2007, 102 (04) :1095-1104
[4]
Lipoic acid as a novel treatment for Alzheimer's disease and related dementias [J].
Holmquist, Lina ;
Stuchbury, Grant ;
Berbaum, Katrin ;
Muscat, Sonja ;
Young, Simon ;
Hager, Klaus ;
Engel, Juergen ;
Munch, Gerald .
PHARMACOLOGY & THERAPEUTICS, 2007, 113 (01) :154-164
[5]
A "Click Chemistry" Approach to the Efficient Synthesis of Multiple Imaging Probes Derived from a Single Precursor [J].
Mindt, Thomas L. ;
Mueller, Cristina ;
Stuker, Florian ;
Salazar, Jean-Frederic ;
Hohn, Alexander ;
Mueggler, Thomas ;
Rudin, Markus ;
Schibli, Roger .
BIOCONJUGATE CHEMISTRY, 2009, 20 (10) :1940-1949
[6]
PET imaging of amyloid in Alzheimer's disease [J].
Nordberg, A .
LANCET NEUROLOGY, 2004, 3 (09) :519-527
[7]
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction [J].
Oddo, S ;
Caccamo, A ;
Shepherd, JD ;
Murphy, MP ;
Golde, TE ;
Kayed, R ;
Metherate, R ;
Mattson, MP ;
Akbari, Y ;
LaFerla, FM .
NEURON, 2003, 39 (03) :409-421
[8]
Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro [J].
Ono, K ;
Hasegawa, K ;
Naiki, H ;
Yamada, M .
JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 75 (06) :742-750
[9]
α-Lipoic acid exhibits anti-amyloidogenicity for β-amyloid fibrils in vitro [J].
Ono, K ;
Hirohata, M ;
Yamada, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 341 (04) :1046-1052
[10]
The traceless Staudinger ligation with fluorine-18: a novel and versatile labeling technique for the synthesis of PET-radiotracers [J].
Pretze, Marc ;
Wuest, Frank ;
Peppel, Tim ;
Koeckerling, Martin ;
Mamat, Constantin .
TETRAHEDRON LETTERS, 2010, 51 (49) :6410-6414